Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 1256 matches for

The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.

International Day of Women and Girls in Science: In conversation with Rebecca Ling

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from alumna Rebecca Ling, now a Clinical Postdoctoral Fellow working in Paediatric Haematology.

International Day of Women and Girls in Science: In conversation with Lena Duma

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from fourth-year Fundamental Scientist, Lena Duma, whose work in the Sir William Dunn School of Pathology focuses on a DNA repair system in cells in order to better understand how certain cancer treatments work.

International Day of Women and Girls in Science: In conversation with Hannah Baillie

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from third-year Fundamental Scientist, Hannah Baillie, who works in the Department of Chemistry investigating acute myeloid leukaemia, an aggressive type of blood cancer.

International Day of Women and Girls in Science: In conversation with Aglaia Skolariki

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from second-year Clinical Research Training Fellow, Aglaia Skolariki, whose DPhil examines how abnormal cell division in aggressive cancers drives particular genetic changes, and how these changes shape the immune system’s ability to recognise and respond to tumour cells.

International Day of Women and Girls in Science: In conversation with Safiyah Mohamed

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from first-year Fundamental Scientist Safiyah Mohamed, who is currently working in the Department of Clinical Neurosciences on research aiming to understand the biology of adult brain tumours.

International Day of Women and Girls in Science: In conversation with Jess Caterson

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from first-year Clinical Research Training Fellow Jess Caterson, who works at the Big Data Institute in the Nuffield Department of Population Health on research aiming to help modernise and digitalise surgical care through the use of wearable technology.

[Video] Patient and Public Involvement with Oxford Cancer

The World Cancer Day theme 2025-2027 “United by Unique” places people at the centre of care and their stories at the heart of the conversation. At Oxford Cancer, we are committed to supporting Patient and Public Involvement (PPI) in research; we aim to build an inclusive community of PPI representatives who are involved in the design and delivery of cutting-edge cancer projects.

Treatment of tumours with sound: new high-intensity focused ultrasound machine installed

A new state-of-the-art high-intensity focused ultrasound (HIFU) machine has been installed at the Churchill Hospital, giving Oxford University Hospitals (OUH) cancer patients access to the latest in this innovative technology.

Oxford Cancer to launch innovative new funding scheme to support patient-led research ideas

Catriona Gilmour Hamilton, Oxford Cancer's Patient and Public Involvement (PPI) Manager, discusses our brand new PPI-Led Pump Priming Scheme, which will launch in Spring 2026.

New clinical study launched examining the role of insulin in breast cancer treatment response

A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.

OVM-200: Phase Ia Results of Novel Survivin Cancer Vaccine

Researchers from the Jiang Group in the Department of Oncology have published Phase Ia clinical trial results for OVM-200, a novel cancer vaccine targeting survivin. The first-in-human trial, published in eClinicalMedicine, reports promising early safety and immunogenicity findings in patients with advanced solid tumours.

Rewiring T cell co-receptors to improve the safety of cancer immunotherapy

A new study from the Dushek and van der Merwe labs in the Sir William Dunn School of Pathology demonstrates a novel strategy to reduce dangerous off-target effects in engineered T cell therapies.

Winners of DPhil in Cancer Science Onco-Innovation Project Sandpit Announced

Congratulations to the following DPhil in Cancer Science students — Michael Bryan, Eva Hanlon, Raul Cioca, Aglaia Skolariki, Nicole Cianci, Roy Rosman Nathanson, Alexandra Petukhova-Greenstein, Anna Prazmo, and Dylan Muldoon — who have been awarded research funding through the 2025 DPhil in Cancer Science Onco-Innovation Project Sandpit.

New NIHR Oxford Senior Research Fellows named

Eight mid-career researchers identified as having the potential to become future leaders in translational research have been appointed to the next cohort of NIHR Oxford Senior Research Fellows. Those named include Rubeta Matin, Oxford Research Lead for Dermatology Skin Cancer Clinical Trials, and Dr Sarah Gooding, Cancer Research UK Clinician Scientist based at the Weatherall Institute of Molecular Medicine.

Cancer inequalities: Empowering inclusive cancer research

A recent article on cancer inequalities - written by Cancer Research UK experts, including Oxford's MRC WIMM Director, Professor KJ Patel - discusses why inclusive research is essential to beat cancer for everyone.

Oxford researchers win first and second place in MRC's 2025 Festive Science Image Competition.

2nd place was awarded to Nathalie Lövgren, DPhil Student, and Dr Iain Tullis, Senior Postdoctoral Researcher, in the Physics and Biology of FLASH Radiation Research Group at the University of Oxford. Nathalie and Iain's snowflake-inspired image was based on their work investigating a potential new radiation treatment for cancer.

The Translational Histopathology Laboratory achieves Good Clinical Laboratory Practice accreditation.

The Translational Histopathology Laboratory (THL), part of the Oxford Experimental Cancer Medicine Centre (ECMC), has achieved Good Clinical Laboratory Practice (GCLP) accreditation, marking an important milestone in the delivery of high-quality, standardised tissue analysis for the cancer research community in Oxford.

Kendra Perez-Smith receives Outstanding Contribution to Sustainability Award

Kendra Perez-Smith, Translational Support Unit (TSU) Manager in the Department of Oncology, has received an Outstanding Contribution to Sustainability Award in recognition of her innovation and leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.

Oxford-built multi-agent assistant for cancer care to be piloted in collaboration with Microsoft

Researchers at the University of Oxford have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.

Oxford University and Brazil Ministry of Health Sign Letter of Intent to strengthen cancer care across Brazil

The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.

Load More